For the quarter ended April 2023, HealthEquity (HQY) reported revenue of $244.43 million, up 18.8% over the same period last year. EPS came in at $0.50, compared to $0.27 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $239.85 million, representing a surprise of +1.91%. The company delivered an EPS surprise of +21.95%, with the consensus EPS estimate being $0.41.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Total HSA Assets: $22.32 billion versus the three-analyst average estimate of $23.30 billion.
Total HSA investments: $8.21 billion compared to the $8.57 billion average estimate based on three analysts.
HSAs Accounts: 8.05 million versus the three-analyst average estimate of 8.03 million.
Total Accounts: 14999 thousand compared to the 15120.22 thousand average estimate based on two analysts.
Total HSA cash: $14.11 billion compared to the $14.98 billion average estimate based on two analysts.
Revenue- Service revenue: $105.11 million compared to the $111.11 million average estimate based on four analysts. The reported number represents a change of +0.7% year over year.
Revenue- Custodial revenue: $94.44 million versus the four-analyst average estimate of $85.42 million. The reported number represents a year-over-year change of +59.1%.
Revenue- Interchange revenue: $44.88 million versus the four-analyst average estimate of $44.72 million. The reported number represents a year-over-year change of +6.9%.
View all Key Company Metrics for HealthEquity here>>>
Shares of HealthEquity have returned +8.2% over the past month versus the Zacks S&P 500 composite's +4.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report